Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
| Current Price | ₹47.39 |
|---|---|
| Market Cap | ₹232 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 24.6 |
| Return on Equity | 10.23% |
| 52-Week Range | ₹40.50 – ₹62.00 |
| Beta (1Y) | 0.26 |
1. Pharmaceutical Products-100%
Syschem (India) Ltd. is trading at ₹47.39, with a market capitalisation of ₹232 Cr.
Syschem (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Syschem (India) Ltd. has a P/E of 24.6 and a return on equity of 10.23%.